Merck & Co. Inc. (MRK): Price and Financial Metrics

Merck & Co. Inc. (MRK): $121.44

0.08 (-0.07%)

POWR Rating

Component Grades

Momentum

C

Stability

B

Sentiment

Quality

B

Add MRK to Watchlist
Sign Up

MRK Price/Volume Stats

Current price $121.44 52-week high $130.24
Prev. close $121.52 52-week low $99.14
Day low $121.13 Volume 8,311,800
Day high $122.51 Avg. volume 8,638,911
50-day MA $123.31 Dividend yield 2.56%
200-day MA $110.91 Market Cap 307.56B

MRK Stock Price Chart Interactive Chart >

MRK POWR Grades

  • Quality is the dimension where MRK ranks best; there it ranks ahead of 94.35% of US stocks.
  • MRK's strongest trending metric is Quality; it's been moving up over the last 26 weeks.
  • MRK ranks lowest in Momentum; there it ranks in the 6th percentile.

MRK Stock Summary

  • MERCK & CO INC's market capitalization of $290,829,829,351 is ahead of 99.48% of US-listed equities.
  • MRK's went public 38.03 years ago, making it older than 92.92% of listed US stocks we're tracking.
  • In terms of volatility of its share price, MRK is more volatile than merely 3.1% of stocks we're observing.
  • Stocks that are quantitatively similar to MRK, based on their financial statements, market capitalization, and price volatility, are ASML, INTC, QCOM, ABBV, and NFLX.
  • Visit MRK's SEC page to see the company's official filings. To visit the company's web site, go to www.merck.com.

MRK Valuation Summary

  • MRK's price/earnings ratio is 60; this is 105.83% higher than that of the median Healthcare stock.
  • MRK's price/sales ratio has moved up 2.4 over the prior 243 months.

Below are key valuation metrics over time for MRK.

Stock Date P/S P/B P/E EV/EBIT
MRK 2023-12-29 4.7 6.7 60.0 35.6
MRK 2023-12-28 4.6 6.7 59.8 35.5
MRK 2023-12-27 4.6 6.6 59.4 35.3
MRK 2023-12-26 4.6 6.6 59.2 35.2
MRK 2023-12-22 4.6 6.6 59.2 35.2
MRK 2023-12-21 4.5 6.5 58.5 34.8

MRK Growth Metrics

    The 3 year net income to common stockholders growth rate now stands at 68.83%.
  • Its 4 year net income to common stockholders growth rate is now at 133.51%.
  • The year over year cash and equivalents growth rate now stands at 22.56%.
MRK's revenue has moved up $10,426,000,000 over the prior 15 months.

The table below shows MRK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 58,974 19,696 15,260
2022-06-30 57,169 18,891 16,579
2022-03-31 53,978 17,079 14,180
2021-12-31 48,704 14,109 13,049
2021-09-30 49,151 13,084 7,197
2021-06-30 48,548 10,460 5,571

MRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MRK has a Quality Grade of B, ranking ahead of 77.57% of graded US stocks.
  • MRK's asset turnover comes in at 0.535 -- ranking 75th of 682 Pharmaceutical Products stocks.
  • XTNT, ACOR, and BDSI are the stocks whose asset turnover ratios are most correlated with MRK.

The table below shows MRK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.535 0.675 0.129
2021-03-31 0.529 0.670 0.158
2020-12-31 0.538 0.677 0.171
2020-09-30 0.542 0.712 0.276
2020-06-30 0.550 0.701 0.260
2020-03-31 0.571 0.701 0.256

MRK Price Target

For more insight on analysts targets of MRK, see our MRK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $93.38 Average Broker Recommendation 1.52 (Moderate Buy)

Merck & Co. Inc. (MRK) Company Bio


Merck & Co., Inc.d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.(Source:Wikipedia)


MRK Latest News Stream


Event/Time News Detail
Loading, please wait...

MRK Latest Social Stream


Loading social stream, please wait...

View Full MRK Social Stream

Latest MRK News From Around the Web

Below are the latest news stories about MERCK & CO INC that investors may wish to consider to help them evaluate MRK as an investment opportunity.

5 Biggest Lawsuits in 2023 That Could Hit Your Wallet

From the resumption of student loan repayments to charges against the world's largest cryptocurrency exchange, several 2023 court cases could affect consumers.

Yahoo | December 28, 2023

Merck & Co., Inc. (NYSE:MRK) Shares Could Be 50% Below Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Merck fair value estimate is US$215 Merck is estimated to be...

Yahoo | December 28, 2023

20 Most Expensive Drugs in the World

In this article, we will take a look at the 20 most expensive drugs in the world. If you want to skip our discussion on the pharmaceutical industry, you can go directly to the 5 Most Expensive Drugs in the World. The health of the global population is being adversely affected due to numerous factors, […]

Yahoo | December 27, 2023

Rethinking Immunotherapy for Cancer: When Is the Best Time to Stop?

Immune-boosting drugs extend cancer patients’ lives and deliver billions in sales to drugmakers, but some patients might be getting more of the drugs than they need.

Yahoo | December 26, 2023

January Effect: 3 Under-the-Radar Stocks Poised for a New Year Jump

Are you looking to profit from the January effect?

Yiannis Zourmpanos on InvestorPlace | December 24, 2023

Read More 'MRK' Stories Here

MRK Price Returns

1-mo -4.37%
3-mo 14.76%
6-mo 14.71%
1-year 19.85%
3-year 71.86%
5-year 72.34%
YTD 12.10%
2023 1.01%
2022 49.42%
2021 -2.91%
2020 -7.20%
2019 22.27%

MRK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MRK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!